Cogent Biosciences Stock Soars: A Year of Gains and a $4.5M Sell
Cogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
Learn about the best cash back rewards cards that come with no fees. Maximize your benefits today!
23,366 articlesCogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
A high-stakes legal clash between Archer Aviation and Joby could swing how investors price the whole eVTOL space. Her...
Imagine income investments that don’t just pay a dividend, they propel total returns. This article highlights three d...
What if chair kevin warsh just flipped the script on Fed communications? This analysis breaks down potential market r...
Investors are urged to rethink risk in today’s markets: volatility is temporary, but liquidity squeezes and balance-s...
Policy shifts in California could ripple through the multifamily loan market. This guide explains what to watch, how ...
A practical guide to interpreting FRPH's Q2 2025 earnings transcript. Learn what to watch, how numbers fit the story,...
A prominent investment advisor just made a sizable play in a well-known theme park company. This article dives into t...
A biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...
ExxonMobil is not just drilling and refining anymore. This article explores how the company might evolve toward a bro...
Mortgage rates hovering near 5% are shifting the math for buyers and investors alike. This guide breaks down what a r...
Investors are weighing bets on critical metals as supply chains shift and demand from EVs and renewables climbs. This...